Determining the ideal column and initial method conditions can be time consuming and challenging without a risk-based, statistical approach. Learn more about automating column selection and initial method conditions from the column screening experiments.
Column screening without a systematic approach during method development can be time-consuming. In this tip we will discuss an automated approach to column screening using Empower and Fusion QbD®.
Our MLCM series continues with a video demonstrating how scoring reports in Empower track and document key method parameters and help build analytical control strategies to ensure consistent method performance.
Our MLCM series continues with an overview of how Empower is an important tool for implementing MLCM approaches to address numerous method-related challenges.
Get ready for our new video blog (VLOG) series featuring Empower as an important tool to implement method lifecycle management (MLCM). The first VLOG in the series is a preview on the method challenges you can address with Empower and an MLCM approach.
In our most recent Method Lifecycle Management webinar held Improving Analytical Method Performance Through Quality Risk Management and a Design of Experiments Approach, Joseph A. Turpin, Director of Chromatography Products and Services at S-Matrix Corporation and Tran Pham, Business Development Manager at Waters Corporation, presented an overview of Quality by Design approaches to analytical method development (AQbD), the regulatory views on this approach, examples of design of experiments in AQbD, and case studies demonstrating software assisted AQbD method development.
Waters recently surveyed 100 method developers from innovator and generic pharmaceutical companies to better understand their existing challenges and views on Method Lifecycle Management (MLCM). We’ll share with you the top questions and findings from our survey results.
Waters recently partnered with United States Pharmacopeia (USP) experts to host a webinar discussing the upcoming changes in the pending USP General Chapter on chromatography that will provide increased flexibility for gradient methods. Here’s an extended Q&A from the webinar.
“Assuming continuous improvement is a worthy goal, there is every reason to improve validated chromatographic methods if you’re working with the right instrument technology,” says Eric Grumbach of Waters. See what that means for developing and transferring methods for biologic drugs.
Retaining and separating highly polar, water-soluble organic compounds has been a challenge for separations scientists who prefer reversed-phase chromatography as their technique of choice. See how Waters has addressed these analytical challenges with our T3 columns.
